Evidence map›Paper›PMID 36994212›Full record

ArticleFrontiers in oncology2023

Diet and physical activity interventions in Black and Latina women with breast cancer: A scoping review.

Margaret S Pichardo, Tara Sanft, Leah M Ferrucci, Yaideliz M Romero-Ramos, Brenda Cartmel, Maura Harrigan, Ana I Velazquez, Oluwadamilola M Fayanju, Eric P Winer, Melinda L Irwin

Open access · goldFull text readScoping Review
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Structural Racism, Lifestyle Behaviors, and Obesity-related Cancers among Black and Hispanic/Latino Adults in the United States: A Narrative Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Margaret S PichardoDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Tara SanftYale Cancer Center, New Haven, CT, United States.
Leah M FerrucciDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Yaideliz M Romero-RamosDepartment of Biology, University of Puerto Rico-Humacao, Humacao, PR, United States.
Brenda CartmelDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Maura HarriganYale Cancer Center, New Haven, CT, United States.
Ana I VelazquezDepartment of Medicine, Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
Oluwadamilola M FayanjuPerelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, United States.
Eric P WinerYale Cancer Center, New Haven, CT, United States.
Melinda L IrwinDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Yale Cancer Center · USHospital of the University of Pennsylvania · USUniversity of California, San Francisco · USUniversity of Pennsylvania · USUniversity of Puerto Rico at Humacao · PR

Funding

A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherenceR01CA207753 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L, SANFT, TARA B · 2017 to 2021
$3.5M
Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health DisparitiesK08CA241390 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FAYANJU, OLUWADAMILOLA M. · 2019 to 2023
$1.1M
NCI NIH HHS K08 CA241390NCI NIH HHS R01 CA207753
6 · The paper itself

Abstract

Background: A growing number of lifestyle interventions are being developed to promote weight loss and adoption of a healthful lifestyles among breast cancer survivors; yet Black and Latina women remain underrepresented. Purpose: We performed a scoping review of the available peer-reviewed literature to describe and compare the content, design, methods, and primary outcomes of current diet and/or physical activity (PA) interventions after a breast cancer diagnosis among Black and Latina women. Methods: We queried PubMed, EMBASE, CINAHL, MEDLINE, and Clinicaltrials.gov up to October 1, 2022, to identify all randomized controlled trials of diet and/or PA after diagnosis of breast cancer with a majority (>50%) of Black or Latina participants. Results: Twenty-two randomized controlled trials were included in this review (five efficacy, twelve pilot, five on-going). Nine trials were among Latinas (two diet, four PA, and three diet/PA), six among Blacks (one PA and five diet/PA) and seven included both populations (five PA and two diet/PA), all of which examined different endpoints. Two of the five efficacy studies achieved their Conclusions: Most of the trials we identified were pilot or feasibility studies and of short duration, demonstrating the need for large randomized controlled efficacy lifestyle interventions among Black and Latina breast cancer survivors. Culturally tailored programing was limited but is an important component to incorporate in future trials in these populations.

Indexed as

Black/African American womenbreast cancerdiet interventionenergy balanceHispanic/Latina womenphysical activity interventionrandomized controlled (clinical) trialsurvivorship

Identifiers

PMID36994212
PMCPMC10040823
OpenAlexW4324089152

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read195
identifiers read16
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.